Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Regardless of genotype, offspring of VIP-deficient female mice exhibit developmental delays and deficits in social behavior.

Lim MA, Stack CM, Cuasay K, Stone MM, McFarlane HG, Waschek JA, Hill JM.

Int J Dev Neurosci. 2008 Aug;26(5):423-34. doi: 10.1016/j.ijdevneu.2008.03.002. Epub 2008 Mar 14.

2.

Regulation of postimplantation mouse embryonic growth by maternal vasoactive intestinal peptide.

Spong CY, Lee SJ, McCune SK, Gibney G, Abebe DT, Brenneman DE, Hill JM.

Ann N Y Acad Sci. 1999;897:101-8. Review.

PMID:
10676439
3.

Vasoactive intestinal peptide in neurodevelopmental disorders: therapeutic potential.

Hill JM.

Curr Pharm Des. 2007;13(11):1079-89. Review.

PMID:
17430171
4.

VIP regulation of embryonic growth.

Hill JM, McCune SK, Alvero RJ, Glazner GW, Brenneman DE.

Ann N Y Acad Sci. 1996 Dec 26;805:259-68; discussion 268-9. Review.

PMID:
8993408
5.
6.

A VIP hybrid antagonist: from developmental neurobiology to clinical applications.

Gozes I, Fridkin M, Brenneman DE.

Cell Mol Neurobiol. 1995 Dec;15(6):675-87. Review.

PMID:
8719036
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk